Webinar | Is your natural food dye compliant, shelf-stable, and ready to scale?
24th July | 12 PM ET: Register Now

Frontier Medicines

Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.
2018
101-250
San Francisco, California, United States
  • Drug Discovery and Development
  • Pharmaceuticals Packaging

Investment Funding

Last Funding Stage

Series C

Total Funding Amount

256.M

Last Funding Amount

20.M

Last Funding Date

25-06-2024

Startup Stage

Late Stage Venture

Lead Investors

Deerfield Management, RA Capital Management, DCVC Bio, Deerfield, MPM Capital

Revenue

$1M to $10M

People

Founders

About

Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines. Its platform integrates advanced computational approaches and machine learning to discover and pharmacologically target new binding pockets on proteins that make them accessible to small-molecule drug discovery and development.

Something missing or incorrect on this page? Help us enrich this information